Nebivolol prevents anthracycline-induced cardiotoxicity. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2016 / 08 / 160828085847.htm ...

A recent review in Medicine Plus offers profound insights into anthracycline-induced cardiotoxicity (AIC), exploring its mechanisms and therapeutic strategies, contributing to safer oncological ...

We know that anthracyclines destroy myocytes. This is well established from the cumulative dose versus congestive heart failure relationship, from extensive myocardial biopsy experience, from the ...

Leukemia - c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia Skip to main content Thank you for visiting nature.com.

Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. ... Narayan HK, Zemljic-Harfp AE. Molecular mechanisms of anthracycline cardiovascular toxicity. Clin Sci (Lond). 2021;135 ...

Background: Pembrolizumab in combination with carboplatin and paclitaxel (CT), followed by 3-weekly anthracycline and cyclophosphamide (AC), or administered in the reverse order, has become the ...